Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review
Abstract Introduction The risk of infections associated with biological drugs (BD) and Janus kinase inhibitors (JAKi) has been extensively explored in the literature. However, there is a dearth of studies that evaluate both pharmacological groups together and, furthermore, compare them. Here, we rev...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Adis, Springer Healthcare,
2024-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|